
Results
2
2 companies
MedinCell
Market Cap: €882.7m
Engages in the research and development of biodegradable polymer-based processes for the controlled and prolonged delivery of active pharmaceutical ingredients into the human body and animals in France.
MEDCL
€24.40
7D
-1.9%
1Y
40.7%
DBV Technologies
Market Cap: €748.7m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
DBV
€2.46
7D
-3.3%
1Y
55.5%